AOP-Wiki

API

All KERs

Showing 901 to 925 of 3129 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

2651	1496: Increased proinflammatory mediators	398: Activation, Dendritic Cells	Apr 28, 2022	Aug 1, 2022	1 AOP 39: Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response
3052	1496: Increased proinflammatory mediators	1439: Systemic acute phase response	Sep 19, 2023	Jan 20, 2025	1 AOP 237: Substance interaction with lung resident cell membrane components leading to atherosclerosis
1074	1032: Increased, secretion of local growth factors	1033: Increased, proliferation of mesenchymal cells	Nov 29, 2016	Dec 3, 2016	1 AOP 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1075	1032: Increased, secretion of local growth factors	1034: Increased, IGF-1 (mouse)	Nov 29, 2016	Dec 3, 2016	1 AOP 163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
1129	1032: Increased, secretion of local growth factors	1089: Increased, Cell Proliferation (mesothelium)	Nov 29, 2016	Dec 3, 2016	1 AOP 171: Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.
1624	1032: Increased, secretion of local growth factors	1456: Differentiation of fibroblasts	Jul 26, 2017	Jul 26, 2017	None
1625	1032: Increased, secretion of local growth factors	1457: EMT	Jul 26, 2017	Jul 26, 2017	None
1092	1050: Increased, secretion of LH from anterior pituitary	1051: Hyperplasia, ovarian stromal cells	Nov 29, 2016	Dec 3, 2016	1 AOP 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
2581	1050: Increased, secretion of LH from anterior pituitary	1972: Increased, Steroidogenic acute regulatory protein (StAR)	Feb 26, 2022	Mar 1, 2022	1 AOP 440: Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia
1088	1047: Increased, secretion of GnRH from hypothalamus	1049: Increased, secrection of FSH from anterior pituitary	Nov 29, 2016	Dec 3, 2016	1 AOP 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
1089	1047: Increased, secretion of GnRH from hypothalamus	1050: Increased, secretion of LH from anterior pituitary	Nov 29, 2016	Mar 1, 2022	2 AOPs 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse 440: Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia
3715	1047: Increased, secretion of GnRH from hypothalamus	2137: Increase, Gonadotropins concentration in plasma	Jan 29, 2026	Feb 3, 2026	4 AOPs 623: Activation, estrogen receptor alpha leads to persistent vaginal cornification via increased kisspeptin release 637: Activation, estrogen receptor alpha leads to increased uterine weight via earlier proliferation of cells of the uterine lining 639: Activation, estrogen receptor alpha leads to precocious puberty via increased kisspeptin release 640: Activation, estrogen receptor alpha leads to decreased fertility via prolonged estrus cycle
1090	1049: Increased, secrection of FSH from anterior pituitary	1051: Hyperplasia, ovarian stromal cells	Nov 29, 2016	Dec 3, 2016	1 AOP 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
1091	1049: Increased, secrection of FSH from anterior pituitary	1052: Hyperplasia, ovarian epithelium	Nov 29, 2016	Dec 3, 2016	1 AOP 165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
1308	1242: Increased, Second Messenger Production	1191: Increased, Non-genomic signaling	Nov 29, 2016	Dec 3, 2016	1 AOP 200: Estrogen receptor activation leading to breast cancer
3780	2420: Increased, RAR activation	1889: premature meiosis, male germ cells	Apr 24, 2026	Apr 24, 2026	1 AOP 400: Inhibition of CYP26B1 activity in fetal testis leading to reduced fertility
1215	1163: Increased, Reproductive Success	1164: Increased, Population	Nov 29, 2016	Dec 3, 2016	2 AOPs 195: 5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase 204: 5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase
1704	1497: Recruitment of inflammatory cells	1498: Loss of alveolar capillary membrane integrity	Jan 5, 2018	May 18, 2023	1 AOP 173: Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
1964	1497: Recruitment of inflammatory cells	1115: Increase, ROS	Jul 3, 2019	Jul 3, 2019	2 AOPs 303: Frustrated phagocytosis-induced lung cancer 409: Frustrated phagocytosis leads to malignant mesothelioma
2354	1497: Recruitment of inflammatory cells	1868: Hyperinflammation	Apr 20, 2021	Feb 8, 2023	2 AOPs 392: Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation 468: Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
2491	1497: Recruitment of inflammatory cells	1931: Disruption of the intestinal barrier	Oct 19, 2021	Oct 19, 2021	None
2492	1497: Recruitment of inflammatory cells	1932: GI disorders	Oct 19, 2021	Oct 19, 2021	None
2543	1497: Recruitment of inflammatory cells	1954: Gut dysbiosis	Dec 15, 2021	Dec 15, 2021	None
2658	1497: Recruitment of inflammatory cells	780: Increase, Cytotoxicity (epithelial cells)	May 25, 2022	May 25, 2022	1 AOP 451: Interaction with lung resident cell membrane components leads to lung cancer
2761	1497: Recruitment of inflammatory cells	1496: Increased proinflammatory mediators	Sep 1, 2022	Sep 1, 2022	1 AOP 468: Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)

Key Event Relationships (KERs)

All KERs